Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms BTX 2640, BTX-2640 |
Target |
Mechanism PDE4 inhibitors(Phosphodieterase 4 inhibitors), Proteolysis |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | US | - |